Answers are grounded in this paper and cite their sources.
Background: Atypical hemolytic uremic syndrome (aHUS) is a relatively rare disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal dysfunction due to gene mutation of complement factors leading to dysregulated activation of the alternative complement pathway. Mutation of CD46 or membrane cofactor protein accounts for 5-20 percent of cases of atypical HUS. Clinical description: Here we report a 7-year-old boy with recurrent episodes of acute kidney injury and thrombocytopenia associated with diarrheal episode who was subsequently found to be having CD46 mutation. He was negative for anti-complement factor H (20AU/ml, ref 0-100 AU/ml). Renal ultrasonography showed normal kidney size with increased echogenicity. With a diagnosis of HUS with AKI and stage 1 hypertension, the patient was managed with amlodipine with monitoring of fluid and electrolyte status. The child underwent three sessions of hemodialysis. After one and half months of the episode, the patient got admitted for the third time with complaints of abdominal pain, hematuria, and oliguria. This episode was not associated with diarrhoea. His whole exome sequencing tested for mutation implicated in atypical HUS revealed a homozygous deletion (77bp) variant in Exon 14 of the CD46 gene. Patient was finally diagnosed with atypical HUS due to CD46 (MCP) mutation. Conclusion: HUS presenting in the context of a diarrhoeal episode should not always be assumed to be diarrhoea-associated HUS and in the recurrence of such episodes, screening for the genetic cause/complement mutation is crucial to establish underlying etiology and deciding therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Priyadarshini et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: